Furthermore, the Kaplan–Meier method was employed to analyze the impact of combined TRIM55 and NF90 expression on the clinical outcomes of HCC patients, revealing that the TRIM55-low & NF90-high group exhibited a worse prognosis compared to the TRIM55-high & NF90-low group (Fig. 6F). This evidence concerns the gene TRIM55 and hepatocellular carcinoma.